SCHEMBL16200513

SCHEMBL16200513

CCC(=O)NC1CCN(CCOC)CC1

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.47
CCR8 P51685 1/20 0.45
HTR4 Q13639 2/20 0.45
ACKR3 P25106 1/20 0.44
CHRM1 P11229 7/20 0.44
KDM4E B2RXH2 2/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
MAPT P10636 1/20 0.43
SIGMAR1 Q99720 1/20 0.43
NPSR1 Q6W5P4 1/20 0.42
KDM1A O60341 1/20 0.42
ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28754536 0.91 HRH3 (0.58) HRH3L3MBTL1CCR8HTR4CHRM1
SCHEMBL21341791 0.85 HRH3 (0.40) HRH3L3MBTL1CCR8HTR4ACKR3
SCHEMBL21472208 0.85 HRH3 (0.40) HRH3L3MBTL1CCR8HTR4ACKR3
SCHEMBL25389091 0.84 KDM1A (0.47) L3MBTL1HTR4ACKR3KDM4EKMT2A
SCHEMBL12332732 0.84 LTA4H (0.54) HTR4ACKR3CHRM1KDM4EKMT2A
SCHEMBL24744482 0.83 L3MBTL1 (0.62) HRH3L3MBTL1CCR8CHRM1KDM4E
SCHEMBL17513083 0.83 SMN1; SMN2 (0.57) HRH3L3MBTL1CCR8CHRM1SIGMAR1
SCHEMBL27517725 0.83 LTA4H (0.53) HTR4ACKR3KDM4EKMT2AMEN1
SCHEMBL23711916 0.82 L3MBTL1 (0.50) HRH3L3MBTL1CCR8HTR4CHRM1
SCHEMBL12304479 0.80 HTR4 (0.49) HTR4ACKR3CHRM1KDM4EKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483249-B1 PYRIMIDINE DERIVATIVES AS PROTEIN TYROSINE KINASE 2 INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2015-12-23 EP disclosed
EP-2408752-B1 SUBSTITUTED PYRIMIDINES FOR THE TREATMENT OF CANCER BOEHRINGER INGELHEIM INT (DE) 2015-08-12 EP disclosed
EP-2435411-B1 2,4-DIAMINOPYRIMIDINES FOR THE TREATMENT OF DISEASES CHARACTERISED BY EXCESSIVE OR ABNORMAL CELL PROLIFERATION BOEHRINGER INGELHEIM INT (DE) 2014-10-29 EP disclosed